found that IGFs inhibited DC-mediated anti-tumor immunity through regulating ERK1/2 phosphorylation and p38 dephosphorylation, and IGF inhibitor NVP-AEW541 restored DC-mediated antigen presentation process (30). The gene discussed is IGF1; the disease is neoplasm.